Bone loss after denosumab, only partial protection with zoledronate

This report investigates whether a single infusion of zoledronate might also be an effective option to prevent bone loss after long-term denosumab treatment in postmenopausal patients is discontinued.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news